Peter Kleist, MD, MFPM RCP-UK, is a specialist in pharmaceutical medicine (CH) and medical director, Novartis Pharma Schweiz AG, Suedbahnhofstrasse 14d, CH-3007 Bern, Switzerland, email: firstname.lastname@example.org.
Stopping a Trial Early for Treatment Benefit: Pros & Cons
Real examples from recent studies illustrate the risks associated with making such a delicate decision.
Women and Trials: When Is Gender a Consideration?
Adequate female representation is mandatory, but gender differences should not be overestimated.
2 Clarke Drive Cranbury, NJ 08512